DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Daniel Rizzo - 1 Rizzo - 1
Top related locs:
Aptargroup U.S
Top related orgs:
Jefferies - 1 OTC Narcan - 1 pharma - 1

Search resuls for: "OTC Narcan"


2 mentions found


☆ Jefferies says buy this little-known injectable drug delivery maker with more than 30% upside
  + stars: | 2024-10-14 | by ( Samantha Subin | ) www.cnbc.com   time to read: +1 min
It's time to buy shares of this under-the-radar injectable delivery and beauty packaging maker with more than 30% upside potential, according to Jefferies. Analyst Daniel Rizzo upgraded shares of Aptargroup to a buy rating, saying that new pharmaceutical delivery products should drive 10% sales growth on a compound annual basis through 2027. Along with the upgrade, Rizzo boosted his price target by 39% to $215 a share, representing 33% upside from Friday's close. The firm also forecasts that the company can drive 7% to 11% pharmaceuticals sales growth over the next 10 years, given that 80% of its delivery systems are protected by intellectual property tools such as patents. "The stock is up ~30% YTD ... but as new products help earnings accelerate, we expect multiple expansion to help support another ~30% increase."
Persons: Daniel Rizzo, Rizzo Organizations: Jefferies, OTC Narcan, pharma Locations: Aptargroup, U.S
☆ U.S. FDA panel backs OTC opioid overdose drug, proposes label changes
  + stars: | 2023-02-16 | by ( Bhanvi Satija Pratik Jain | Bhanvi Satija | Pratik Jain | ) www.reuters.com   time to read: +3 min
Feb 15 (Reuters) - Emergent BioSolutions Inc's (EBS.N) over-the-counter version of opioid overdose reversing drug received unanimous support from U.S. Food and Drug Administration's panel of advisers, sending shares of the contract drugmaker up nearly 16% after market. The vote puts the naloxone-based treatment Narcan on track to potentially become the first opioid overdose drug to be sold OTC nationwide. Naloxone rapidly reverses or blocks the effects of an overdose, restoring normal respiration. However, most panelists emphasized that OTC use of the nasal spray was safe and proposed ways to improve its labeling, to avoid using the drug wrong. Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020.
0 next >>
Total: 2